Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Journal of Pathology

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)61684-7PMID 11438465PMCID PMC1850400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary Malignant Neuroepithelial Tumors of the Kidney: A Clinicopathologic Analysis of 146 Adult and Pediatric Cases from the National Wilms' Tumor Study Group Pathology Center

  2001cited by this paper
• The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

  2001influential reference
• Contemporary approach to the classification of renal epithelial tumors.

  2000cited by this paper
• Contemporary approach to the classification of renal epithelial tumors.

  2000cited by this paper
• Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center.

  2000cited by this paper
• Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney.

  2000cited by this paper
• Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach.

  2000cited by this paper
• Contribution of molecular genetic data to the classification of sarcomas.

  2000cited by this paper
• Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes.

  1999cited by this paper
• Clear cell sarcoma of soft parts: report of a case primary in the kidney with cytogenetic confirmation.

  1999cited by this paper
• Alveolar soft part sarcoma: a review and update.

  1999cited by this paper
• A first-generation X-inactivation profile of the human X chromosome.

  1999cited by this paper
• Alveolar soft‐part sarcoma: Further evidence by FISH for the involvement of chromosome band 17q25

  1998cited by this paper
• Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.

  1998cited by this paper
• Renal-cell carcinoma in children: a different disorder from its adult counterpart?

  1998cited by this paper
• Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression.

  1998cited by this paper
• ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.

  1998cited by this paper
• Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma

  1997cited by this paper
• EWS/FLI-1 fusion transcripts in three peripheral primitive neuroectodermal tumors of the kidney.

  1997cited by this paper
• Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features.

  1997cited by this paper
• Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.

  1996cited by this paper
• Diagnostic Pitfalls In The Cytological Interpretation Of Breast Cancer

  1996cited by this paper
• The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene.

  1996cited by this paper
• Diagnostic Transmission Electron Microscopy of Tumors

  1996influential reference
• Soft Tissue Tumors

  1995cited by this paper
• Renal adenocarcinoma in an 8-year-old child, with a t(X;17)(p11.2;q25).

  1995cited by this paper
• Soft tissue tumors, 3rd edition, 1995: F.M. Enzinger and S.W. Weiss. Mosby, St Louis, £160

  1995cited by this paper
• Immunophenotype and ultrastructure of alveolar soft part sarcoma.

  1993cited by this paper
• Keratin immunohistochemistry: update of applications and pitfalls.

  1993cited by this paper
• Crystal-deficient alveolar soft part sarcoma.

  1993cited by this paper
• Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint.

  1991cited by this paper
• Alveolar soft part sarcoma with psammoma bodies

  1990cited by this paper
• Alveolar soft‐part sarcoma. A clinico‐pathologic study of half a century

  1989cited by this paper
• Alveolar soft part sarcoma

  1988cited by this paper
• Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Alveolar soft‐part sarcomas. Structurally characteristic tumors of uncertain histogenesis

  1952cited by this paper

• Central Role of MITF/TFE Family Transcription Factors in Diverse Clear and Granular Cell Tumors.

  2026cites this paper
• TFE-Altered Renal Cell Carcinoma: A Contemporary Review With Practical Insights and Diagnostic Pearls for Surgical Pathologists.

  2026cites this paper
• Role of Molecular Testing in Diagnosis of Renal Neoplasms

  2026cites this paper
• SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation.

  2025cites this paper
• Hyperferritinemia revealing renal carcinoma with TFE3 gene translocation: a rare case report

  2025cites this paper
• Renal cell tumours with papillary architecture: evolving concepts, classification and new emerging entities

  2025cites this paper
• Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation

  2025cites this paper
• Primary Intracranial Alveolar Soft Part Sarcoma: Systematic Review

  2025cites this paper
• TFE3/TFEB Altered Renal Cell Carcinomas in End-Stage Renal Disease Setting: A Single Institution Clinicopathological Study of 4 Cases.

  2025cites this paper
• A Rare Case of Alveolar Soft Part Sarcoma (ASPS) in the Posterior Cervical Triangle Mimicking a Paraganglioma on 68Ga-DOTANOC PET/CT.

  2025cites this paper
• Renal Cell Carcinoma With MED15 Exon 13–TFE3 Exon 6 Fusion Lacks Cystic Architecture

  2025cites this paper
• MiT family translocation carcinomas of the kidney and related entities

  2025cites this paper
• An autopsy case of TFE3-rearranged PEComa-like neoplasm with systematic embolization involving the heart.

  2025cites this paper
• Alveolar Soft Part Sarcoma: An Updated Review.

  2025cites this paper
• Masters of Gene Expression: Transcription Factors in Pediatric Cancers

  2025cites this paper
• The evolution of renal cell carcinoma classification

  2025cites this paper
• Analysis of Clinicopathologic Features and Imaging Findings of TFE3-Rearranged Renal Cell Carcinoma.

  2025cites this paper
• Paediatric renal tumours: an update on challenges and recent developments

  2025cites this paper
• Paediatric renal tumors: An insight into molecular characteristics, histomorphology and syndromic association

  2025cites this paper
• MAPK1IP1L::TFE3-rearranged renal cell carcinoma: a novel fusion adding to the differential diagnosis of oncocytic renal neoplasms

  2025cites this paper
• TFE3-rearranged and TFEB-altered renal cell carcinoma: from classification to real-life. Insights from a national Italian survey

  2025cites this paper
• Molecularly defined renal cell carcinomas: practical approaches for surgical pathologists

  2025cites this paper
• MED15::TFE3 fusion renal cell carcinoma with extensive cystic change: A clinicopathologic and molecular genetic study of 2 cases, with an emphasis on differential diagnosis.

  2024cites this paper
• Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers

  2024cites this paper
• Molecular uropathology: what a practising pathologist should know

  2024cites this paper
• ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97

  2024cites this paper
• TFE3-rearranged Head and Neck Neoplasms

  2024cites this paper
• A framework for target discovery in rare cancers

  2024cites this paper
• TFE3-Rearranged PEComa/PEComa-like Neoplasms

  2024cites this paper
• TFE3‐rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape

  2024cites this paper
• TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum

  2024cites this paper
• The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates

  2024cites this paper
• YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer

  2024cites this paper
• Outcome after treatment with axitinib in children, young adults, and adults with renal cell carcinoma: a narrative review.

  2024cites this paper
• The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications.

  2024cites this paper
• Renal mass biopsy — a practical and clinicopathologically relevant approach to diagnosis

  2024cites this paper
• ASPSCR1::TFE3-mediated upregulation of insulin receptor substrate 2 (IRS-2) activates PI3K/AKT signaling and promotes malignant phenotype.

  2024cites this paper
• PHF1::TFE3-positive fibromyxoid sarcoma? Report of 2 cases and review of 13 cases of PHF1::TFE3-positive ossifying fibromyxoid tumor in the literature.

  2024cites this paper
• Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis

  2024cites this paper
• Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma

  2023cites this paper
• TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma

  2023cites this paper
• Renal cell carcinoma in the contralateral kidney with TFE3 gene translocation following chemotherapy for childhood nephroblastoma: A case report and literature review

  2023cites this paper
• Metastatic alveolar soft part sarcoma of the kidney in a young female

  2023influential citation
• ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97

  2023cites this paper
• Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report

  2023cites this paper
• Pathology of Alveolar Soft Part Sarcoma

  2023cites this paper
• Establishment and Characterization of a TFE3-rearranged Renal Cell Carcinoma Cell Line (FU-UR-2) With the PRCC-TFE3 Fusion Transcript

  2023cites this paper
• Exploring G-quadruplex structure in PRCC-TFE3 fusion Oncogene: Plausible use as anti cancer therapy for translocation Renal cell carcinoma (tRCC)

  2023cites this paper
• The Transition From Localized to Metastatic: A Case Report of Adult TFE3-Positive Xp11.2 Translocation Renal Cell Carcinoma

  2023cites this paper
• A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer

  2023cites this paper
• Balancing lysosome abundance in health and disease

  2023cites this paper
• PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3‐rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma

  2023cites this paper
• The Recent Advances in Molecular Diagnosis of Soft Tissue Tumors

  2023cites this paper
• WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist

  2023cites this paper
• MED15::TFE3 Renal Cell Carcinomas: Report of Two New Cases and Review of the Literature Confirming Nearly Universal Multilocular Cystic Morphology

  2023cites this paper
• Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature☆, ☆☆.

  2023cites this paper
• Management of translocation carcinomas of the kidney

  2023cites this paper
• A case report and literature review on nephrogenic alveolar soft part sarcoma: clinicopathological manifestations and genetic features

  2023cites this paper
• Imaging findings, clinical and pathological characters of 28 patients with Xp11.2/TFE3 translocation renal cell carcinoma

  2023cites this paper
• Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma

  2023cites this paper
• TFE3 Rearrangement and Expression in Renal Cell Carcinoma

  2022cites this paper
• Up-regulation of NMRK2 mediated by TFE3 fusions is the key for energy metabolism adaption of Xp11.2 translocation renal cell carcinoma.

  2022cites this paper
• Xanthomatous Giant Cell Renal Cell Carcinoma

  2022cites this paper
• Complex Elucidation of Cells-of-Origin in Pediatric Soft Tissue Sarcoma: From Concepts to Real Life, Hide-and-Seek through Epigenetic and Transcriptional Reprogramming

  2022cites this paper
• A review of neoplasms with MITF/MiT family translocations.

  2022cites this paper
• Chameleon TFE3-translocation RCC and How Gene Partners Can Change Morphology: Accurate Diagnosis Using Contemporary Modalities.

  2022cites this paper
• PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion

  2022cites this paper
• Proteogenomic characterization of MiT family translocation renal cell carcinoma

  2022cites this paper
• Alveolar soft part sarcoma of the left kidney in children.

  2022cites this paper
• How New Developments Impact Diagnosis in Existing Renal Neoplasms.

  2022cites this paper
• Minimally invasive cytologic evaluation leading to the diagnosis of TFE3‐rearranged renal cell carcinoma: A case report

  2022cites this paper
• Alveolar soft part sarcoma of the pectoralis mimicking a breast mass: A case report

  2022cites this paper
• TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms

  2022cites this paper
• MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical management.

  2022cites this paper
• Primary Alveolar Soft Part Sarcoma of Bone.

  2022cites this paper
• French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer.

  2022cites this paper
• New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

  2021cites this paper
• One Case of Extrarenal Renal Carcinomas Associated with Xp11.2 Translocations/TFE3 Gene Fusions and Literature Review

  2021cites this paper
• CMAR_A_297457 2419..2431

  2021cites this paper
• Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93‐01, 2001 and UK‐IMPORT database: A report of the SIOP‐Renal Tumor Study Group

  2021influential citation
• Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis

  2021cites this paper
• A new risk-scoring system to predict Xp11.2 translocation renal cell carcinoma in adults

  2021cites this paper
• Estradiol increases risk of topoisomerase IIβ-mediated DNA strand breaks to initiate Xp11.2 translocation renal cell carcinoma

  2021cites this paper
• Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners

  2021cites this paper
• Diagnosis of soft tissue tumors using immunohistochemistry as a surrogate for recurrent fusion oncoproteins.

  2021cites this paper
• A Rare Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: Case Report of 8 Cases and Review of the Literature

  2021cites this paper
• Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted Therapy.

  2021cites this paper
• Kidney cancer: from genes to therapy.

  2021cites this paper
• Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report

  2021cites this paper
• Tumors masquerading as type 2 papillary renal cell carcinoma: pathologists' ever-expanding differential diagnosis for a heterogeneous group of entities.

  2021cites this paper
• Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas

  2021cites this paper
• A 25 year perspective on advances in the pathologic assessment and diagnosis of urologic cancers.

  2021cites this paper
• Common Diagnostic Challenges and Pitfalls in Genitourinary Organs, With Emphasis on Immunohistochemical and Molecular Updates.

  2021cites this paper
• Nuclear translocation of ASPL-TFE3 fusion protein creates favorable metabolism by mediating autophagy in translocation renal cell carcinoma

  2021cites this paper
• The Clinicopathological Features of Epithelioid Undifferentiated Sarcoma with TFE3 Amplification with One Case Report

  2021cites this paper
• Translocation carcinomas of the kidney

  2021cites this paper
• Clinicopathological Findings on 28 Cases with XP11.2 Renal Cell Carcinoma

  2020cites this paper
• Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses

  2020cites this paper
• Pediatric Solid Tumors

  2020cites this paper
• Tuberous sclerosis complex and the kidney

  2020cites this paper